Tam Tri Medical Group
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Tam Tri Medical Group - overview
Established
2013
Location
Ho Chi Minh City, -, Vietnam
Primary Industry
Healthcare
About
Based in Vietnam, Tam Tri Medical Group provides comprehensive healthcare services, focusing on medical consulting and management across a network of hospitals and multi-specialty clinics, ensuring quality patient care. Tam Tri Medical Group, established in 2013 and headquartered in Ho Chi Minh City, Vietnam, focuses on healthcare consulting and management. The company has completed 2 deals, with the most recent deal on June 9, 2025, where VinaCapital exited its stake. The total amount raised by the company amounts to USD 17.
60 mn after its latest funding round, which was a Growth round led by VinaCapital. Tập Đoàn Y Khoa Tâm Trí, operating under the brand TMMC Health Care, provides comprehensive healthcare consulting and management services across a network of hospitals and multi-specialty clinics throughout Vietnam. Their primary offerings include a range of medical services, from primary care to specialized treatments, designed to cater to diverse patient needs. The company aims to enhance accessibility to high-quality healthcare for all individuals, ensuring that patient satisfaction remains a fundamental priority.
TMMC Health Care serves a broad client base, including patients from various demographics and backgrounds, as well as families seeking reliable medical care for their loved ones. Their services are primarily targeted at the Vietnamese market, though their operational model may influence the potential for expanding services into neighboring regions. Tập Đoàn Y Khoa Tâm Trí generated revenue of USD 327,877. 80 in 2023.
The company reported an EBITDA of USD -435,710. 80 for the same year. The organization utilizes a structured service delivery model that encompasses both direct-to-consumer and business-to-business transactions. Patients typically engage with the company through a fee-for-service model, paying for specific medical consultations and treatments at their facilities.
Collaborations with insurance providers may further facilitate access to their services for insured patients. Tam Tri Medical Group is looking to leverage its recent funding from the Growth round to enhance its service delivery and expand its operational capacity. Plans are underway to introduce new healthcare products and refine existing services, with anticipated launches set for late 2025. The company is also eyeing expansion into neighboring countries in Southeast Asia by 2026, which aligns with its goal to increase accessibility to high-quality healthcare services in the region.
This strategic growth plan aims to capitalize on its operational model and broaden its client base.
Current Investors
VinaCapital
Primary Industry
Healthcare
Sub Industries
Hospitals
Website
www.tmmchealthcare.com
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only
Tam Tri Medical Group - financials
| Fiscal Year Ended | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 5,330,000,000 | - | 5,100,000,000 | 5,400,000,000 | 7,200,000,000 | 7,200,000,000 | 7,200,000,000 | - | - | - |
| % Revenue Growth (YoY) | - | - | - | 5.9% | 33.3% | - | - | - | - | - |
| EBITDA (USD) | (10,520,809,414) | - | (467,564,085) | (81,313,330) | (583,538,372) | (626,764,670) | 548,171,586 | - | - | - |
| Operating Income (USD) | (10,520,809,414) | - | (467,564,085) | (81,313,330) | (583,538,372) | (626,764,670) | 548,171,586 | - | - | - |
| Operating Margin | (197.4%) | - | (9.2%) | (1.5%) | (8.1%) | (8.7%) | 7.6% | - | - | - |
| % EBITDA Margin | (197.4%) | - | (9.2%) | (1.5%) | (8.1%) | (8.7%) | 7.6% | - | - | - |
| NET Income (USD) | (8,863,913,820) | - | (62,488,153,706) | (4,176,726,802) | (33,741,576,956) | (39,753,403,647) | (15,201,956,311) | - | - | - |
| % Net Margin | (166.3%) | - | (1225.3%) | (77.3%) | (468.6%) | (552.1%) | (211.1%) | - | - | - |
Tam Tri Medical Group - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Unspecified Exit | Completed | Tam Tri Medical Group | - | ||||||||
| Growth | Completed | Tam Tri Medical Group | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.